Chretien, A., Fauriat, C., Orlanducci, F., Rey, J., Borg, G. B., Gautherot, E., . . . Olive, D. (2017). NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia. Oncotarget.
শিকাগো স্টাইলে সাইটেশনChretien, Anne-Sophie, et al. "NKp30 Expression Is a Prognostic Immune Biomarker for Stratification of Patients With Intermediate-risk Acute Myeloid Leukemia." Oncotarget 2017.
এমএলএ সাইটেশনChretien, Anne-Sophie, et al. "NKp30 Expression Is a Prognostic Immune Biomarker for Stratification of Patients With Intermediate-risk Acute Myeloid Leukemia." Oncotarget 2017.
সতর্কবাণী: সাইটেশন সবসময় 100% নির্ভুল হতে পারে না.